In addition, the t(11;14) abnormality also confers unique biology to malignant plasma cells in MM, demonstrating higher expression of antiapoptotic protein BCL‐2 as compared to other antiapoptotic proteins MCL‐1 and BCL‐xL [9]. This evidence concerns the gene BCL2 and Miyoshi myopathy.